# Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

> **NCT01860183** · PHASE4 · COMPLETED · sponsor: **Clinical Hospital Merkur** · enrollment: 76 (actual)

## Conditions studied

- Kidney Transplantation
- Kidney Failure

## Interventions

- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT01860183
- **Lead sponsor:** Clinical Hospital Merkur
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-06
- **Final completion:** 2016-06-01
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2021-10-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01860183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01860183, "Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01860183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*